Dicot Pharma AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Net Income	-57.7	-44.16	-31.76	-27.17	-17.54	Upgrade
Depreciation & Amortization	-	0.01	0.01	0.01	0	Upgrade
Other Operating Activities	-	-	-	-	0.06	Upgrade
Change in Accounts Receivable	-2	-1.32	-0.07	-0.16	0.1	Upgrade
Change in Inventory	-2	-1.91	-1.49	-	0.44	Upgrade
Change in Accounts Payable	-	1.12	0.84	1.09	-	Upgrade
Change in Other Net Operating Assets	2.8	1.03	2.75	0.38	0.68	Upgrade
Operating Cash Flow	-58.9	-45.23	-29.71	-25.87	-16.26	Upgrade
Capital Expenditures	-	-	-	-	-0.04	Upgrade
Investing Cash Flow	-	-	-	-	-0.04	Upgrade
Issuance of Common Stock	125	97.26	9.92	40.42	29.38	Upgrade
Other Financing Activities	-	-14.07	-1.16	-4.56	-4.98	Upgrade
Financing Cash Flow	125	83.19	8.76	35.87	24.4	Upgrade
Net Cash Flow	66.1	37.96	-20.95	10	8.1	Upgrade
Free Cash Flow	-58.9	-45.23	-29.71	-25.87	-16.29	Upgrade
Free Cash Flow Per Share	-0.05	-0.09	-0.24	-0.40	-0.57	Upgrade
Levered Free Cash Flow	-38.32	-29.26	-17.86	-15.72	-9.8	Upgrade
Unlevered Free Cash Flow	-38.32	-29.22	-17.83	-15.72	-9.8	Upgrade
Change in Net Working Capital	1.26	1.08	-2.03	-1.3	-1.22	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.